In silico design of angiotensin-converting enzyme 2 (ACE2) recombinant protein to block the S1 protein pathway of COVID-19 virus
<p>Coronavirus is a large family of viruses that includes the common cold and the SARS virus. The Chinese corona, or coronavirus, is a new respiratory virus that began in late 2019 and early 2020 in the province of Hubby and Wuhan, China, and became known as COVID-19. The COVID-19 virus genome...
Tallennettuna:
Päätekijä: | Yaser Ghazi (Tekijä) |
---|---|
Aineistotyyppi: | Kirja |
Julkaistu: |
Open Journal of Proteomics and Genomics - Peertechz Publications,
2020-07-25.
|
Aiheet: | |
Linkit: | Connect to this object online. |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Samankaltaisia teoksia
-
Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
Tekijä: Daniel eClayton, et al.
Julkaistu: (2015) -
Angiotensin converting enzyme 2 (ACE2) - the major receptor for SARS-CoV-2 virus
Tekijä: Sonia Frankowska, et al.
Julkaistu: (2021) -
Potential use of the S-protein-Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019
Tekijä: Long Feng, et al.
Julkaistu: (2022) -
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
Tekijä: Jingwei Bian, et al.
Julkaistu: (2021) -
Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies
Tekijä: Murtala Bello Abubakar, et al.
Julkaistu: (2021)